70
CHEN ET AL.
using NaOCl as an terminal oxidant with various reaction NMR (400 MHz, CDCl3): d 13.72 (1H, s, OH); 8.39 (1H, d,
solvents. The catalysts showed high chiral induction in the CHN); 7.28–7.15 (10H, m, ArH); 7.06 (1H, s, ArH); 6.94 (1H,
epoxidation of bulkier olefins with short reaction time, and s, ArH); 4.73 (1H, s, CH); 4.37 (1H, d-d, CH); 3.74–3.69 (2H,
the dimeric salen Mn(III) complex 6a can be effectively m, NH2); 3.48 (2H, s, CH2); 2.40–2.33 (4H, m, CH2); 1.46
recycled for six times. To the best of our knowledge, this (4H, s, CH2); 1.41 (9H, s, C(CH3)3); 1.38–1.20 (4H, m, CH2);
is the first report of dimeric Mn(III)-salen complexes with 0.89–0.82 (6H, m, CH3). LC-MS: m/z 514.0 [M 1 H]1. Anal.
inherent phase-transfer capability as recyclable catalysts Calcd for C34H47N3O: C, 79.49; H, 9.22; N, 8.18. Found: C,
for the asymmetric epoxidation of nonfunctionalized 79.54; H, 9.16; N, 8.16.
alkenes in the presence of ionic liquids.
Preparation of Two Chiral Dinucleating Ligands and
Corresponding Mn(III) Complexes
EXPERIMENTAL SECTION
General Remarks
Synthesis of 5,5-methylenedi-[(R,R)-{N-(3-tert-butyl-
salicylidine)-N0-(30-tert-butyl-50-(N,N-dibutylmethylene)
1H NMR spectra were recorded on a Mercury Plus 400
spectrometer with TMS as internal standard. IR spectra
were obtained on a Nicolet 170SX FTIR spectrophotome-
ter as KBr discs. ESI-HRMS were performed on a Bruker
Daltonics APEXII47e mass spectrometer. LC-MS were
performed on a Bruker Daltonics Esquire6000 mass spec-
trometer. Elemental analyses were taken using a Perkin
Elmer 240C analytical instrument. All reactions were moni-
tored by TLC. TLC was performed on glass plates coated
with silica gel 60F254. The crude products were purified
by flash chromatography. High-performance liquid chro-
matograph with Daicel Chiralcel OD-H chiral column was
used for the measurements (hexane:i-PrOH 5 99:1).
salicyladhyde)}-1,2-cyclohexanediamine]
(5a). The
ethanol (10 ml) solution of (1R,2R)-N-(2-hydroxyl-3-tert-
butyl-5-(N,N-dibutylmethylene)-1-amino-2-cyclohexaneimine
(4a) (2 mmol) was added slowly to the ethanol (10 ml) so-
lution of 5,50-methylene-di-3-tert-butylsalicyladehyde (1
mmol). The mixture was stirred under refluxing for 8 h,
and then solvent was removed under reduced pressure to
afford the crude product. The crude product was purified
by flash chromatography (SiO2, petroleum ether/EtOAc 5
1
10:1) to generate a yellow oil (92%). H NMR (400 MHz,
CDCl3): d 13.74 (2H, s, OH); 13.70 (2H, s, OH); 8.28 (2H, s,
CHN); 8.22 (2H, s, CHN); 7.21 (2H, s, ArH); 7.05 (2H, s,
ArH); 6.93 (2H, s, ArH); 6.74 (2H, s, ArH); 3.67 (2H, s,
CH2); 3.39 (4H, s, CH2); 3.33 (4H, s, CH); 2.36 (8H, s,
CH2); 1.88 (8H, s, CH2); 1.70 (8H, s, CH2); 1.60 (8H, s,
CH2); 1.42 (18H, s, C(CH3)3); 1.39 (18H, s, C(CH3)3); 1.28–
1.23 (8H, m, CH2); 0.96–0.78 (12H, m, CH3). ESI-HRMS:
m/z 1163.8974 [M 1 H]1. Anal. Calcd for C75H114N6O4: C,
77.41; H, 9.87; N, 7.22. Found: C, 77.49; H, 9.81; N, 7.31.
FTIR (KBr): 3345, 2929, 2862, 1631, 1441, 1385, 1266, 1205,
Preparation of Two Chiral Half-Unit Ligands (4a and 4b)
Synthesis of (1R,2R)-N-[2-hydroxyl-3-tert-butyl-5-
(N,N-dibutylmethylene)]-1-amino-2-cyclohexaneimine
(4a). The CHCl3 (10 ml), solution of 2-hydroxyl-3-tert-
butyl-5-(N,N-dibutylmethylene)benzaldehde3 (1 mmol)
was added slowly to the CHCl3 (10 ml) solution of
(1R,2R)-(2)-diaminocyclohexane (1 mmol) with vigorous
stirring at 08C. The reaction mixture was stirred for 48 h
before stirring was discontinued, then the solvent was
removed under reduced pressure affording the crude
product. The crude product was purified by flash chroma-
tography (SiO2, petroleum ether/EtOAc 5 4:1) to gener-
ate a yellow oil (68%). 1H NMR (400 MHz, CDCl3): d 13.82
(1H, s, OH); 8.35 (1H, d, CHN); 7.06 (1H, s, ArH); 6.92
(1H, s, ArH); 4.12 (1H, d-d, CH); 3.38 (1H, s, CH); 3.47
(2H, s, CH2); 2.92–2.74 (2H, m, NH2); 2.40–2.36 (4H, m,
CH2); 2.06–1.60 (8H, m, CH2); 1.43 (4H, s, CH2); 1.39 (9H,
s, C(CH3)3); 1.30–1.24 (4H, m, CH2); 0.90–0.82 (6H, m,
CH3). LC-MS: m/z 416.1 [M 1 H]1. Anal. Calcd for
C26H45N3O: C, 75.13; H, 10.91; N, 10.11. Found: C, 75.21;
H, 10.87; N, 10.93.
1181, 1094, 1023, 963, 750, 689 cm21
.
Synthesis of 5,5-methylenedi-[(R,R)-{N-(3-tert-butyl-
salicylidine)-N0-(30-tert-butyl-50-(N,N-dibutylmethylene)
salicyladhyde)}-1,2-diphenylethylenediamine] (5b).
The ethanol (10 ml) solution of (1R,2R)-N-(2-hydroxyl-3-
tert-butyl-5-(N,N-dibutylmethylene)-amino-1,2-diphenyletha-
neimine (4b) (2 mmol) was added slowly to the ethanol
(10 ml) solution of 5,50-methylene-di-3-tert-butylsalicylade-
hyde (1 mmol) with vigorous stirring at room temperature
The reaction mixture was stirred for 16 h, then solvent was
removed under reduced pressure affording the crude prod-
uct. The crude product was purified by flash chromatogra-
phy (SiO2, petroleum ether/EtOAc 5 8:1) to generate a
1
yellow oil (91%). H NMR (400 MHz, CDCl3): d 13.63 (2H,
Synthesis of (1R,2R)-N-(2-hydroxyl-3-tert-butyl-5- s, OH); 13.59 (2H, s, OH); 8.33 (2H, s, CHN); 8.25 (2H, s,
(N,N-dibutylmethylene)]-1-amino-1,2-diphenylethanei- CHN); 7.23–7.09 (20H, m, ArH); 7.08 (2H, s, ArH); 7.04
mine (4b). The ethanol (10 ml) solution of 2-hydroxyl-3- (2H, s, ArH); 6.97 (2H, s, ArH); 6.70 (2H, s, ArH); 4.74–
tert-butyl-5-(N,N-dibutylmethylene)benzaldehde3 (1 mmol) 4.67 (4H, m, CH); 3.67 (2H, s, CH2); 3.48 (4H, s, CH2);
was added slowly to the ethanol (10 ml) solution of (1R,2R)- 2.40 (8H, s, CH2); 1.58 (8H, s, CH2); 1.42 (18H, s,
(1)-diphenyldiamine (1 mmol) with vigorous stirring at 08C. C(CH3)3); 1.37 (18H, s, C(CH3)3); 1.29–1.23 (8H, m, CH2);
The reaction mixture was stirred for 48 h before stirring 0.98–0.82 (12H, m, CH3). ESI-HRMS: m/z 1359.9287 [M 1
was discontinued, then the solvent was removed under H]1. Anal. Calcd for C91H118N6O4: C, 80.37; H, 8.75; N,
reduced pressure affording the crude product. The crude 6.18. Found: C, 80.46; H, 8.86; N, 6.11. FTIR (KBr): 3318,
product was purified by flash chromatography (SiO2, petro- 2955, 2865, 1627, 1440, 1384, 1264, 1208, 1159, 1094, 1062,
1
leum ether/EtOAc 5 2:1) to generate a yellow oil (86%). H 908, 734, 700 cm21
.
Chirality DOI 10.1002/chir